British Journal of Cancer

FIGURES AND TABLES

FROM:

Irinotecan, docetaxel and oxaliplatin combination in metastatic gastric or gastroesophageal junction adenocarcinoma

L Di Lauro, C Nunziata, M G Arena, P Foggi, I Sperduti and M Lopez

BACK TO ARTICLE
Figure 1 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Figure 1.

Median TTP for all patients.

Full figure and legend (10K)
Figure 2 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Figure 2.

Overall survival for all patients.

Full figure and legend (10K)
Table 1 - Patient's characteristics - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Table 1 - Patient's characteristics.

Full table
Table 2 - Objective response in 40 patients - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Table 2 - Objective response in 40 patients.

Full table
Table 3 - Grade 3//4 haematological toxicity per cycle and per patient - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Table 3 - Grade 3/4 haematological toxicity per cycle and per patient.

Full table
Table 4 - Non-haematological toxicity in 40 patients - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Table 4 - Non-haematological toxicity in 40 patients.

Full table
BACK TO ARTICLE